Debt-to-equity in % of Celularity Inc from Q1 2020 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Celularity Inc quarterly Debt-to-equity history and change rate from Q1 2020 to Q3 2025.
  • Celularity Inc Debt-to-equity for the quarter ending September 30, 2025 was -1.27K %, a 444% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Celularity Inc Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -1.27K -1.64K -444% Sep 30, 2025
Q2 2025 -10.6K -10.9K -3154% Jun 30, 2025
Q1 2025 986 +773 +363% Mar 31, 2025
Q4 2024 535 +371 +227% Dec 31, 2024
Q3 2024 371 +239 +181% Sep 30, 2024
Q2 2024 346 +218 +172% Jun 30, 2024
Q1 2024 213 +69.2 +48.2% Mar 31, 2024
Q4 2023 163 -18.6 -10.2% Dec 31, 2023
Q3 2023 132 -109 -45.1% Sep 30, 2023
Q2 2023 127 -169 -57.1% Jun 30, 2023
Q1 2023 144 +436 Mar 31, 2023
Q4 2022 182 +253 Dec 31, 2022
Q3 2022 240 +291 Sep 30, 2022
Q2 2022 296 +318 Jun 30, 2022
Q1 2022 -292 -270 -1237% Mar 31, 2022
Q4 2021 -70.8 -47.6 -205% Dec 31, 2021
Q3 2021 -50.2 -46.7 -1306% Sep 30, 2021
Q2 2021 -21.9 -16.7 -319% Jun 30, 2021
Q1 2021 -21.8 -12.8 -140% Mar 31, 2021
Q4 2020 -23.2 Dec 31, 2020
Q3 2020 -3.57 Sep 30, 2020
Q2 2020 -5.23 Jun 30, 2020
Q1 2020 -9.08 Mar 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.